News|Articles|December 16, 2024

2024’s Needle-Free Approvals Transform Management of Anaphylaxis, Influenza in Children

Author(s)Joshua Fitch

Needle-free treatments, such as Neffy and FluMist, offer promising alternatives for children and adults with needle phobia, ensuring access to critical care.

In the pediatric population, it is no secret that needle phobia can have an impact on the administration of routine vaccines, injections to prevent allergic reactions, and intravenous uses for blood work.